feed,title,long_url,short_url
Benzinga,"KBR Q3 Earnings Beat Estimates, Lifts FY21 Outlook",https://benzinga.com/news/earnings/21/10/23694620/kbr-q3-earnings-beat-estimates-lifts-fy21-outlook,https://j.mp/3bk8ld2
Benzinga,Edgewise Therapeutics Posts Data From Early-Stage Muscle Wasting Disease Trial,https://benzinga.com/general/biotech/21/10/23696326/edgewise-therapeutics-posts-data-from-early-stage-muscle-wasting-disease-trial,https://j.mp/2XWHeBM
Benzinga,"Takeda's 1H Sales Increase 13%, Reaffirms FY21 Outlook, Announces Share Buyback",https://benzinga.com/general/biotech/21/10/23691750/takedas-1h-sales-increase-13-reaffirms-fy21-outlook-announces-share-buyback,https://j.mp/3Em1IU0
